Abstract
The clinical outcomes and safety of dalbavancin as primary and sequential treatment of gram-positive bacteremia with infective endocarditis were evaluated retrospectively. The clinical success rate was high (92.6%), but in 24 of 27 patients dalbavancin was used only after clearance of bacteria from the bloodstream.
Author supplied keywords
Cite
CITATION STYLE
APA
Tobudic, S., Forstner, C., Burgmann, H., Lagler, H., Ramharter, M., Steininger, C., … Thalhammer, F. (2018). Dalbavancin as primary and sequential treatment for gram-positive infective endocarditis: 2-year experience at the general hospital of vienna. Clinical Infectious Diseases, 67(5), 795–798. https://doi.org/10.1093/cid/ciy279
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free